Computerized system and method for rapid data entry of past medical diagnoses
First Claim
1. A method for optimizing pharmaceutical sales and marketing information based on a prescribing entity'"'"'s prescribing history, the method comprising:
- obtaining a prescribing entity'"'"'s prescription history for a defined time period;
establishing an actual disease prevalence for the prescribing entity based on a frequency relationship between each drug prescribed by the prescribing entity and a disease for which it is prescribed;
determining a general prevalence value for each disease in the general population; and
establishing a weighted disease prevalence profile for the prescribing entity based on a combination of the general prevalence value and the actual prevalence value.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a system and method for electronic and algorithmic data mining of an individual physician'"'"'s prescribing history to determine the approximate distribution of diseases within their practice population for optimizing pharmaceutical sales and marketing. Rapid and large-scale determination of specific clinical safety and efficacy attributes of a marketed drug which are most pertinent and relevant to a given physician, when compared to a competitor'"'"'s drug, are defined and tabularized. Major clinical characteristics taken into account include a drug'"'"'s safety, efficacy, cost, dosing convenience, formulary insurance coverage, side effect profiles, and FDA approval for the intended use. A symbolic representation of knowledge is employed in which the marketed drug and each competitor'"'"'s drug are compared algorithmically against each other with a scoring system that is based upon machine analysis of each major clinical characteristic. The score is further refined according to the number and severity of safety interactions which are relevant to the comparison, and also based upon predicted prevalence of such interactions within a specific physician'"'"'s practice.
-
Citations
19 Claims
-
1. A method for optimizing pharmaceutical sales and marketing information based on a prescribing entity'"'"'s prescribing history, the method comprising:
-
obtaining a prescribing entity'"'"'s prescription history for a defined time period; establishing an actual disease prevalence for the prescribing entity based on a frequency relationship between each drug prescribed by the prescribing entity and a disease for which it is prescribed; determining a general prevalence value for each disease in the general population; and establishing a weighted disease prevalence profile for the prescribing entity based on a combination of the general prevalence value and the actual prevalence value. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method for optimizing pharmaceutical sales and marketing information to a specific prescribing entity, the method comprising:
-
acquiring a prescribing entity'"'"'s prescription history including a listing of prescribed drugs and a frequency of prescription of each drug; determining a disease distribution among the individuals comprising the prescribing entity'"'"'s practice on the basis of the prescription history; establishing a drug safety score on the basis of a severity criteria and a frequency criteria for at least known drug-drug and drug-disease interactions between and among a plurality of substantially similar drugs; and ranking the plurality of substantially similar drugs on the basis of the drug safety score and a prevalence criteria determined by the prevalence of use of a particular drug by the prescribing entity and the prevalence of occurrence of a particular disease within the prescribing entity'"'"'s practice. - View Dependent Claims (9, 10, 11, 12, 13)
-
-
14. A method for optimizing pharmaceutical sales and marketing information to a specific prescribing entity, the method comprising:
- determining a listing of drugs typically prescribed by the prescribing entity;
defining a distribution of disease among the patients of the prescribing entity'"'"'s practice on the basis of drugs prescribed;
scoring a drug being marketed on the basis of a safety criteria with respect to drug-drug interactions against the drugs typically prescribed by the prescribing entity;
scoring a drug being marketed on the basis of an efficacy criteria with respect to disease against the drugs typically prescribed by the prescribing entity; and
identifying superior safety and efficacy criteria of the drug being marketed with respect to the drugs typically prescribed by the prescribing entity. - View Dependent Claims (15, 16, 17, 18, 19)
- determining a listing of drugs typically prescribed by the prescribing entity;
Specification